Medios is a specialized pharmaceutical company founded in 2015 with a mission to enable the most innovative tailored therapies for everybody. The company focuses on specialized medications and the production of patient-specific therapies for severe diseases. Positioned as a pioneer in the Specialty Pharma sector, Medios comprehensively covers all aspects of care for critically ill individuals by acting as a reliable partner for pharmacies, specialist physicians, and pharmaceutical companies. The company emphasizes its understanding of the urgency in providing patients with specialty pharmaceuticals and its unique contribution towards shaping the future of individualized medicine across Europe for everyone. With an aspiration to make the most innovative therapies accessible, Medios serves as a crucial player in the healthcare industry. For more information, visit Impressum and Data Protection.
There is no investment information
No recent news or press coverage available for Medios.